Takao Toshiko, Matsuyama Yutaka, Suka Machi, Yanagisawa Hiroyuki, Kikuchi Masatoshi, Kawazu Shoji
Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Tokyo, Japan.
Department of Biostatistics, School of Public Health, University of Tokyo, Tokyo, Japan.
J Diabetes Complications. 2014 Sep-Oct;28(5):674-8. doi: 10.1016/j.jdiacomp.2014.05.008. Epub 2014 Jun 2.
To analyze time-to-effect relationships between systolic blood pressure (SBP) and the risks of development of nephropathy and retinopathy in patients with type 2 diabetes.
We retrospectively enrolled 647 patients with type 2 diabetes who first visited our hospital between 1995 and 1996, made ≥1 hospital visit per year, had been followed-up for ≥1year, and had undergone ≥4 SBP measurements. Of these, 352 with normoalbuminuria and 516 without retinopathy were followed through June 2012.
Nephropathy developed in 90 patients and retinopathy in 113. Hazard ratios (HRs) for time-dependent SBP-associated nephropathy and retinopathy were the highest during 1year preceding each endpoint or censoring. The HRs for nephropathy had been steadily lower during the preceding 1-17 years, while that for retinopathy had been lower during the preceding 1-5 years and constant during the preceding 5-17 years.
The time-to-effect relationship with SBP differed for the development of nephropathy and retinopathy. The long-term effect was obvious for nephropathy and borderline for retinopathy, while the short-term effect was stronger and evident for both. Continuous SBP lowering is necessary to prevent nephropathy, whereas SBP control during the preceding 5years seems to be important to prevent retinopathy.
分析2型糖尿病患者收缩压(SBP)与肾病和视网膜病变发生风险之间的时效关系。
我们回顾性纳入了647例2型糖尿病患者,这些患者于1995年至1996年间首次就诊于我院,每年至少就诊1次,随访时间≥1年,且进行了≥4次SBP测量。其中,352例为正常白蛋白尿患者,516例无视网膜病变患者,随访至2012年6月。
90例患者发生了肾病,113例发生了视网膜病变。在每个终点或审查前1年期间,时间依赖性SBP相关肾病和视网膜病变的风险比(HRs)最高。在之前的1 - 17年中,肾病的HRs一直较低,而视网膜病变的HRs在之前的1 - 5年较低,在之前的5 - 17年保持稳定。
SBP与肾病和视网膜病变发生的时效关系有所不同。长期效应在肾病中明显,在视网膜病变中临界显著,而短期效应在两者中均更强且明显。持续降低SBP对于预防肾病是必要的,而在之前5年控制SBP对于预防视网膜病变似乎很重要。